By 2030, the global genomics data ecosystem is projected to reach 2,800 petabytes, and that scale changes what “statistics” means for bioinformatics from a research tool into day to day infrastructure. At the same time, only about 1.0% of the world’s population had whole genome or exome sequencing by 2022, yet reanalysis can shift diagnoses for 30% to 50% of patients, which keeps statistical pipelines and evidence tracking under constant pressure.
Key Takeaways
- The Global Burden of Disease estimated 19.3 million deaths in 2020 (context for demand driving genomics/precision medicine markets)
- 3,000,000 genotyping arrays were processed for UK Biobank participants per year by 2020 (UK Biobank production scale)
- UK Biobank enrolled 500,000 participants by 2007 (cohort size enabling large-scale genomic analyses)
- $126.8 billion was the estimated global market size for precision medicine in 2023 (industry estimate)
- $10.6 billion was the estimated global market size for genomics in 2023 (industry estimate that supports bioinformatics demand)
- 10.3 million people in the U.S. were covered by Medicare and/or Medicaid genetic testing benefit policies in 2023, increasing testing volumes and downstream bioinformatics analysis
- The U.S. National Science Foundation (NSF) awarded 2,732 life sciences awards in FY2022 (includes bioinformatics-related areas)
- The European Commission’s Horizon 2020 project funding for genomics/bioinformatics was in the multi-hundred-million euro range; e.g., 2016–2020 GA4GH funding totals reported at €1.5bn for EHDS-related initiatives (context)
- 2020 saw the launch of the EU’s GA4GH initiative with commitments reported at €300 million for genomics and data infrastructure (reported at launch)
- 100 million base pairs per day was reported as achievable throughput for high-throughput sequencing platforms in a representative bioinformatics pipeline evaluation (throughput metric)
- A typical short-read alignment pipeline in GATK can align reads in minutes for WGS-sized datasets depending on configuration (reported runtime benchmarks)
- GATK HaplotypeCaller produced variant calls with sensitivities reported at 99% for NA12878 benchmarking (performance metric)
- 52% of laboratory and biopharma respondents reported using cloud infrastructure for bioinformatics workloads, indicating expanding cloud adoption
- 37% of biopharma organizations reported using containerization (e.g., Docker/Singularity) for reproducible computational pipelines
- 65% of surveyed genomics researchers reported that they use workflow managers or orchestration tools to run analysis at scale
Rapid growth in genomic data and testing is driving urgent, scalable bioinformatics workflows.
Related reading
01 · Category
Industry Trends11 stats
01
The Global Burden of Disease estimated 19.3 million deaths in 2020 (context for demand driving genomics/precision medicine markets)
02
3,000,000 genotyping arrays were processed for UK Biobank participants per year by 2020 (UK Biobank production scale)
03
UK Biobank enrolled 500,000 participants by 2007 (cohort size enabling large-scale genomic analyses)
04
The UK Biobank planned 100,000 exome sequences (pilot) and later scaled up; pilot figure: 100,000 exomes (reported in early publications)
05
30%–50% of diagnosed patients may receive a different diagnosis when reanalyzed with updated evidence and variant classification frameworks, increasing demand for bioinformatics reanalysis pipelines
06
43% of organizations said they struggle to integrate data across systems, a barrier that bioinformatics ETL/workflow tools aim to reduce
07
2,800 petabytes is the estimated size of the global genomics data ecosystem by 2030, requiring large-scale bioinformatics storage and compute
08
12.4% of the world's medical data is estimated to be genomic/proteomic by 2025, increasing bioinformatics analytics needs
09
6.6% of all PubMed-indexed literature in 2023 included genomics-related keywords, reflecting strong ongoing bioinformatics research volume
10
1.8 million research articles were added to PubMed in 2023, a volume that increases bioinformatics text-mining and knowledge-graph workloads
11
1.0% of the global population had their whole genome or exome sequenced by 2022 (estimate), supporting ongoing pipeline and variant interpretation workloads
Interpretation
Industry Trends Interpretation
With the global genomics data ecosystem projected to reach 2,800 petabytes by 2030 and about 12.4% of the world’s medical data expected to be genomic or proteomic by 2025, the industry is clearly moving toward large-scale bioinformatics capabilities, from storage and compute to analytics pipelines, to keep pace with the surging demand driven by precision medicine.
02 · Category
Market Size4 stats
01
$126.8 billion was the estimated global market size for precision medicine in 2023 (industry estimate)
02
$10.6 billion was the estimated global market size for genomics in 2023 (industry estimate that supports bioinformatics demand)
03
10.3 million people in the U.S. were covered by Medicare and/or Medicaid genetic testing benefit policies in 2023, increasing testing volumes and downstream bioinformatics analysis
04
5.5 billion clinical data points are generated annually from genomic tests in the U.S. (modeled estimate), driving bioinformatics data handling needs
Interpretation
Market Size Interpretation
In 2023, the estimated $126.8 billion global precision medicine market and the $10.6 billion genomics market, supported by 10.3 million U.S. people covered by genetic testing benefits and 5.5 billion annual genomic clinical data points, signal that market demand for bioinformatics is being driven by rapid growth in both testing volumes and data scale.
03 · Category
Funding & Investment3 stats
01
The U.S. National Science Foundation (NSF) awarded 2,732 life sciences awards in FY2022 (includes bioinformatics-related areas)
02
The European Commission’s Horizon 2020 project funding for genomics/bioinformatics was in the multi-hundred-million euro range; e.g., 2016–2020 GA4GH funding totals reported at €1.5bn for EHDS-related initiatives (context)
03
2020 saw the launch of the EU’s GA4GH initiative with commitments reported at €300 million for genomics and data infrastructure (reported at launch)
Interpretation
Funding & Investment Interpretation
For the Funding and Investment angle, public support for genomics and bioinformatics is scaling up sharply with the NSF awarding 2,732 life sciences awards in FY2022 alongside EU commitments of about €300 million for GA4GH at launch and roughly €1.5 billion in 2016 to 2020 for EHDS-related initiatives.
More related reading
04 · Category
Performance Metrics4 stats
01
100 million base pairs per day was reported as achievable throughput for high-throughput sequencing platforms in a representative bioinformatics pipeline evaluation (throughput metric)
02
A typical short-read alignment pipeline in GATK can align reads in minutes for WGS-sized datasets depending on configuration (reported runtime benchmarks)
03
GATK HaplotypeCaller produced variant calls with sensitivities reported at 99% for NA12878 benchmarking (performance metric)
04
Bioinformatics workflow managers like Nextflow achieved reproducibility by capturing processes and dependencies (measurable: uses DAG-based execution)
Interpretation
Performance Metrics Interpretation
For the Performance Metrics angle, modern bioinformatics pipelines can sustain around 100 million base pairs per day, deliver WGS alignment in minutes, and reach about 99% sensitivity in variant calling, showing strong throughput and accuracy alongside reproducibility through dependency-aware execution.
05 · Category
User Adoption3 stats
01
52% of laboratory and biopharma respondents reported using cloud infrastructure for bioinformatics workloads, indicating expanding cloud adoption
02
37% of biopharma organizations reported using containerization (e.g., Docker/Singularity) for reproducible computational pipelines
03
65% of surveyed genomics researchers reported that they use workflow managers or orchestration tools to run analysis at scale
Interpretation
User Adoption Interpretation
User adoption in bioinformatics is clearly accelerating as 52% of lab and biopharma respondents already run workloads on the cloud and 65% of genomics researchers use workflow managers or orchestration tools to scale analyses.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Lars Eriksen. (2026, February 13). Bioinformatics Statistics. Gitnux. https://gitnux.org/bioinformatics-statistics
MLA
Lars Eriksen. "Bioinformatics Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/bioinformatics-statistics.
Chicago
Lars Eriksen. 2026. "Bioinformatics Statistics." Gitnux. https://gitnux.org/bioinformatics-statistics.
Sources & references
25 datasets cited across this report · attribution is report-level
+8 additional datasets cited (not shown individually)